Bibliographic record
Abstract
The challenge to diagnose cutaneous eruptions and lesions in patients who have spent time in foreign countries is increasingly common. With the advent of increased global travel, foreign adoptions, immigration, and refugee seekers, rashes that were once relegated to the realm of the exotic and likely to show up in a tropical diseases clinic may now present to a general pediatrician. Furthermore, the pediatric traveler is at increased risk for dermatoses. (1) It behooves the practitioner to be aware of these skin findings, to be able to recognize them and distinguish them from other skin conditions.After completing this article, readers should be able to:Along with the current COVID-19 (coronavirus 2019) outbreak, this review article draws attention to the fact that international travel can introduce unexpected diseases throughout the world.Joseph A. Zenel, MDEditor-in-ChiefIn patients with a travel history, there are different frameworks for organizing an approach to rashes. One approach is to consider the infectious agents present commonly in the countries of exposure. However, this approach will miss many more mundane infections, noninfectious causes of skin disease, and perhaps disease unrelated to travel but occurring coincidentally with travel.Perhaps the most practical approach to skin lesions in those with a travel history is to consider the morphology of the presenting skin findings and to consider the infectious (both tropical and cosmopolitan) as well as noninfectious (both travel-related and non–travel-related) causes of similar skin features. Considering rashes by morphologic pattern allows for a practical starting point for diagnosis. Herein, 7 morphologic patterns are examined in detail with approaches to diagnoses within each group (Table 1).The focus will be on 1) the approach to patients with skin lesions and a history of time spent in other locations, 2) review of the common eruptions seen in such patients and how to distinguish these eruptions from those unrelated to travel, and 3) some key eruptions that should not be missed in the approach to these patients.Much of the data available on diseases in patients who have been to foreign destinations has been collected internationally by the GeoSentinel Surveillance Network. Cutaneous diseases are the third most common group behind respiratory signs and symptoms, diarrhea, and fever in travel-related diseases. (1)(2)(3) Studies of the pediatric traveler are limited, although they compose part of the larger studies on diseases in returning travelers. Lederman et al (1) found that returning travelers with a dermatologic diagnosis had greater odds of being younger than 18 years. As such, data from broader populations are discussed herein.We, therefore, determined a profile of common dermatologic problems in travelers, both tropical and cosmopolitan, from GeoSentinel data (Table 2).There are potential pitfalls when assessing skin disease in the returning traveler. When a patient with a travel history presents with skin lesions or a rash, it is tempting to assume that an exotic infection was picked up during travel. This narrowed approach will often neglect many other possible—although perhaps more mundane—infections that can be acquired during travel. Travel may also be unrelated to an infection incubating before travel but presenting coincidentally with travel. A much broader approach to the patient’s history will ensure attention to other diagnostic considerations. A second pitfall may be to ignore remote infectious exposures for which a latency period causes the skin disease to develop months or years after the exposure. One needs to take into consideration travel-related skin disease in such cases to appropriately acquire the patient’s history.Figure 1 presents a diagnostic framework with which to consider cutaneous disease in the returning traveler.Fever is rarely associated with skin findings. (1) However, fever and morbilliform rash in the returning traveler should alert the physician to consider arboviruses such as dengue and typhoid. Emerging entities to also consider are chikungunya and Zika viruses, and vaccine-preventable cosmopolitan illnesses such as measles.Dengue fever (DF) is one of the most frequent causes of febrile illness among pediatric travelers returning from southeast Asia, Latin America, and the Caribbean. (3) It is transmitted to humans by the mosquito Aedes aegypti. There are 4 serotypes, and immunity after infection is distinct to the serotype. (8)The incubation period of DF ranges from 3 to 14 days, with clinical features including retro-orbital pain, myalgia, arthralgia, and adenopathy. (8) Cutaneous manifestations are found in 50% to 82% of DF-positive cases but may vary in presentation among different age groups. (9) Transient flushing erythema of the face, neck, and chest occurs within the first 24 to 48 hours of fever. (8) Three to 5 days later, a generalized maculopapular rash appears resembling “white islands in a sea of red” as small islets of skin are spared. (8) This confluent rash starts on the extremities and moves centrally, tends to spare the face, and is not usually associated with pruritus. (9) Hemorrhagic manifestations such as petechiae/purpura and a positive tourniquet test result may also be present (Fig 2). (10)Diagnosis is with viral isolation, viral polymerase chain reaction (PCR) positivity, or paired serology (acute and convalescent-phase serum), and management is supportive with fluid therapy. Mosquito avoidance strategies can aid in prevention. (8)Chikungunya is another Aedes mosquito-borne disease, most commonly reported in travelers returning from the Caribbean, particularly Haiti and south central Asia. (11)With an incubation period ranging from 1 to 12 days, the infection presents with acute-onset fever, headache, arthralgia, lymphadenopathy, and a rash that is reported in 30% to 60% of children. (1) This skin eruption initially presents as a flushing erythema of the face, neck, and trunk, which then progresses into a generalized, nonpruritic, morbilliform rash with islands of spared skin 3 to 5 days later (Fig 3). (8)(10) Of note, the cutaneous manifestations of chikungunya vary across different age groups. The initial flushing of the skin has been followed by vesiculobullous lesions in some infants. (12) Chikungunya fever is oftentimes hard to distinguish clinically from the initial stages of DF. (3) With that said, arthralgia is more severe in patients with chikungunya fever, whereas myalgia is the more prominent feature in DF. (13)Laboratory diagnosis is through reverse transcriptase PCR (RT-PCR) and serologic testing; treatment is supportive, and mosquito avoidance is recommended. (12)Zika virus infection is a major global health concern due to recent outbreaks in South and Central America, along with the Caribbean. (14)It is transmitted to humans mainly through A aegypti mosquitoes. Zika virus has an incubation period of 3 to 12 days, and its clinical manifestations include arthralgia, nonpurulent conjunctivitis, and headache. Skin findings are present in 90% of patients. (10)(14) Fever is mild if present. Along with hyperemic conjunctivitis, pruritic micropapular exanthema has been reported as a unique mucocutaneous finding in Zika virus infection. Skin eruption starts on the trunk and descends to the lower body. Petechiae are also found on the palate. (10)Infection can be confirmed with RT-PCR, and treatment is supportive. (10)(14)Typhoid fever is caused by the bacterium Salmonella typhi, which is shed in the stool during the illness and in asymptomatic carriers. It is transmitted through the fecal-oral route. Typhoid fever was found to be the most common cause of fever in children returning from Asia. (15)The incubation period for S typhi can range from 3 to 60 days. (16) Clinical features are prolonged high fever, abdominal pain, and classic cutaneous “rose spots.” These are discrete pink and blanchable macules 2 to 4 mm in diameter appearing on the trunk and abdomen during the second week of the illness (Fig 4). These nonpruritic rose spots last 2 to 5 days and disappear without scarring. (17)(18)Blood culture is the main diagnostic method. (16) Third-generation cephalosporins or azithromycin are first-line treatments. (19) Hand hygiene is one preventive strategy, and a vaccination is available, although its benefit may wane over time, necessitating a booster. (20)Measles remains a major disease in developing countries and is increasingly reported in industrialized countries due to a decline in vaccination rates. (21) It is found mainly in Asia, as well as in Africa and Europe. Children who are not sufficiently vaccinated are at increased risk for contracting this viral illness. (21)Measles virus is mainly transmitted by respiratory droplets and has an incubation period of 7 to 21 days. A classic tetrad of prodromal features includes cough, coryza, conjunctivitis, and Koplik spots. (21) Koplik spots are gray-white papules on an erythematous base and usually appear on the buccal mucosa (Fig 5). (22) A nonpruritic rash develops 2 to 4 days after the onset of symptoms. Erythematous macules and papules first appear on the face and descend toward the extremities, lasting 4 to 7 days (Fig 6). (21) The exanthem is around sebaceous glands and hair follicles and can be mildly hemorrhagic. Patients are infectious from 4 days before to 4 days after rash onset. (22)Laboratory diagnosis is made through serologic testing and RT-PCR of the throat swab and urine. (23) In addition to treating measles symptomatically and treating the complications, there are some therapies that may be helpful. Vaccine administered within 72 hours of contact may limit disease development. The same is true of postexposure intramuscular immune serum globulin provided within 6 days of contact. This can be used for high-risk patients. Adjunct vitamin A treatment reduces blindness and death rates. (24)Of note, the previously mentioned infections could present with a feverless exanthema, and the differential diagnosis of a patient with a morbilliform rash is essentially the same whether or not fever is present.Drug eruption can be a non–travel-related cause of a maculopapular rash. It can be difficult to recognize exanthematous drug eruptions at times because many patients who have nonspecific infectious symptoms are given reaction and other clinical findings can drug eruptions from infectious This is an not to the diagnosis but also to a patient from being as a drug if in fact the rash is due to the infectious an an infection and drug treatment can an by a patient by virus is such an (Fig is to that drug eruptions can and be in the differential diagnosis in patient presenting with skin findings when have been disease is a of of The diagnostic include a fever lasting for at 5 days and 4 of the clinical a rash, conjunctivitis, lymphadenopathy, and in the morbilliform eruption is the most common of the over the trunk and extremities, including the occurs (Fig to the diagnostic of should distinguish it from a travel-related rash. is but of the risk of throughout 2 and the most commonly reported dermatologic illnesses in children in addition to although the present as a and not as a to consider in the differential diagnosis of eruptions include and is a skin caused by of the or It is among the in the pediatric traveler returning from the Caribbean. It is also common in travelers of south central Asia, and Central or South of is associated with skin with on the or in a has a incubation period of days. The eruption initially presents with a erythematous The in the and a rash that progresses at 2 to 5 mm and is pruritic (Fig The is commonly seen on the of the and common include and may be associated with of is and although the eruption is it can be with in children. includes on strategies to contact of skin with such as and of eruptions can from and acquired during travel to a range of or can or and often in a may present as small or discrete or on of the body. The papules may have a that can with are infection is and patients may present with signs of and usually but or can with pruritus. they behind or skin that in most patients without are in travel not as agents of a pruritic rash but also as for many travel-related diseases. such as and are disease is a infection caused by The is in many of America, and history of may not include or exotic time spent in and similar should part of a travel incubation period can vary from 3 to days after the The classic cutaneous of disease is erythema and occurs in the disease This as a small erythematous at the of the and in a presenting as a with with a small of lesions have central (Fig In younger the lesions are more likely to on the or neck, and in children they more on the and disease can present with lesions that appear over symptoms include fever, headache, myalgia, arthralgia, and in the should be clinical because serum may not be for 3 to after infection. A approach with and serologic testing is used in drug is and strategies include and or is an to of the It is common in and tropical and can be seen after to but also and is reported in Asia, America, and Europe. the this eruption presents as papules than as a rash (Fig The eruption is a reaction on pruritic and erythematous papules develop within 24 may as macules and are in to A reaction or fever can and is by headache, and diagnosis of is of in the or and serologic findings can The within 3 but and may be used to symptoms. and in is eruption is a reaction to the of the of sea found in The in with or in such as with This is commonly seen in the Caribbean, and hours of a of which develops into a pruritic with papules are in The rash is particularly in the such as the and The lesions can last 3 to 7 days. is mainly of the rash is and can of the and skin may is a common eruption and may or may not be to travel. cases are or a reaction to a viral illness. can also be seen as a reaction to a infection should be in returning travelers. presents as with a and can vary in from to (Fig can present as or as and not have or and each within 24 to 48 behind skin there are other such as fever or respiratory or to one should consider infections such as testing a stool for and be lesions that last than 48 hours or behind skin or should be than and may including skin is can aid in is a reaction by infections or The most common infectious cause is virus and is to cause a erythema clinical presentation is of erythematous papules that lesions that have 3 of and a (Fig present in a and there is a for the and symptoms include and mild pruritus. of this is includes or if lesions are if can be with the lesions are or in with and consideration should be given to with diagnostic and drug eruption is a eruption occurring in a small of patients can have associated This eruption occurs usually at first to in the or or when there is travel to a eruption is a and can be used to the and of may its or cutaneous are caused by the The infection is through contact with skin or and is common in children. are and on the and are also common on the papules are and skin with discrete these lesions a hard and often within 2 therapies or can be used in is a and disease caused by infection in It can be transmitted through infectious and or contact. lesions present as and are commonly present in In the of the disease, of the and can Clinical diagnosis is confirmed by and are used in is a reaction to and eruptions are asymptomatic and in on the of of and and with scarring. in these patients is positive for and or current in and the reaction to therapy. is a reaction to the into the The is mainly transmitted through which its high in developing countries and The are seen in tropical of Asia, southeast Asia, and Latin of symptoms after is 4 to 6 and eruptions are often found on However, because the and rash are manifestations of the to the the of those features is not to the diagnosis in asymptomatic should be as or are for and can also (Fig are more commonly seen on the and in younger and they are more and in children. of skin of or is is the treatment of for skin infections are a major cosmopolitan cause of dermatoses. is commonly seen in most of the reported in the include or or are found to be the to an along with other cutaneous as of infection. In children younger than 18 years are more likely to develop is a skin of which is the is caused by or are on the face and and and into a and testing are to aid in the diagnosis and treatment of should include for of such as and is caused by the of found in tropical and found in South and Central It is reported in travelers returning from and symptoms are to the and range from mild to severe pain, and with central are by erythematous and which is to and of the skin are also is as and in to days. However, the are usually to such as can be to the lesions to and of and mosquito is to is caused by the of the It can be seen in those with travel to Central and South America, and hygiene and contact with in countries have been for its the at the of an erythematous with a central and a is There may be or fluid are found on the most These are associated with the of children and in are common and may present with and but the can be with a are used for and is recommended. of and is in papules are common lesions presenting as 1 or These in patients who to at as a reaction to or as there is an that starts the and the patient then the each time it an is caused by the transmitted by and are the for the with humans as the The 2 major of include and cutaneous and is acquired in and the the Asia, and is commonly seen in travelers of South and Central an incubation period ranging from to initially as papules on into and with (Fig are usually to in infections and may once the is (Fig These lesions can last for months to and although they may it is often with scarring. with may to lesions of the and appearing after the cutaneous lesions have A common for this is the and it may be by pain, and Of note, to lesions at the are skin lesions that develop years after the infection is of is confirmed with skin or PCR a and more and in diagnosis. is and treatment for is to and includes agents and can be through of and in is a disease caused by This bacterium tends to in the the and with lower of is through or contact and and its may on The is in patients and in in travelers. months to and the disease can limited, or on the immune In of is different than in and the are the most common as macules or (Fig The presentation of is with or in children often on of the and lesions are more common than and symptoms in this age group are found to be common. is mainly clinical by skin and into consideration a patient history and Skin and a skin test can be used as In clinically cases with skin or findings, PCR may the diagnosis is to and for many months to is a disease in tropical commonly children younger than and is by skin contact of infectious occurs in 3 with in Three to 4 after a appears at the of in lesions and in the third of the disease occurs years later with lesions of the and of is also through the of clinical and serologic and patients are with there are many causes of and in children that are noninfectious and may or may not be to travel, including foreign are cosmopolitan infections that present with eruptions but could in a infections such as and are among the most common seen in children. These infections are transmitted through contact with humans and such as hygiene and by due to the high of in children. usually presents with lesions that as small papules that These eruptions have a and a that as the (Fig is usually although for and culture may aid in the diagnosis. is with has clinical that include on the and may include (Fig may also be present in patients with often in the and of should be confirmed by and culture of because it can be difficult to from and of the drug is for of such as or can from during travel may cause of in a patient who in a may if or an time in a with As many patients who to another will an skin disease for which they were but in a is an eruption to be caused by or is more likely to in the second and third of and is common in children younger than years. There are a in its presentation in children that should be presents with an initial a erythematous 2 to 6 in It is often for but it to with drug and is usually followed by a generalized eruption that occurs much in children and is in The eruption has a for the trunk and presents as papules with a of often up in a pattern resembling the of a (Fig lesions are also more common in children. is although is to distinguish it from other is treatment is if for pruritus. or can be contact a can be such as seen with or presents as a vesiculobullous whereas to other agents often presents as a In or contact with the may result in an The initial erythematous to pruritic and 12 to 48 hours after exposure. can of contact is in and although lesions are and can be used on testing can distinguish from other of similar dermatoses. is a eruption caused by skin to agents and exposure. are most often along with or 24 to 72 hours after erythematous lesions appear that may be by or macules and lesions are may be used to noninfectious causes of vesiculobullous lesions to in in the returning traveler are and to such as such as are more likely to be during the patient’s travel than and cutaneous and in in a causes lesions in the can be by or this diagnosis should be in in the returning is commonly seen in children the of 2 to 5 years and is usually caused by the of some of S presents as and than 3 in diameter that often the may be the of the can be seen at the of the with a or in the These lesions on the face, trunk, and The of infection in is usually in the can be and are used for and disease is caused by and is through the respiratory or contact. are seen in Asia, and the commonly in and in children. in and incubation period of this viral illness is 3 to 7 days, and manifestations include fever, symptoms, and mucosa and The erythematous lesions are found on the and in or in (Fig can be and severe in patients with to the or can appear in of and is and the of is usually mild and with treatment being mainly supportive diseases are caused by that the cutaneous in In the younger the most common is disease of which presents as of lesions with or fluid resembling a of (Fig lesions often on the of lesions and may be is made through with and or is the drug eruptions are an cutaneous drug drug eruption is one lesions at hours after of the often and The trunk, and mucosa are most commonly the of eruption once the has (Fig Clinical diagnosis on history, and the is to an for that this article, for this article are at
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.001 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.002 | 0.001 |
| Bibliometrics | 0.000 | 0.003 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.001 |
| Insufficient payload (model declined to judge) | 0.000 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".